ArticleClinical and experimental gastroenterology2026
Real-Life Use of Subcutaneous Biologicals and JAK Inhibitors in IBD Maintenance Therapy: Treatment Continuation, Switching Patterns, and Concomitant Medications.
Mirkka Koivusalo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.